Optimal Propofol Plasma Concentration during Upper Gastrointestinal Endoscopy in Young, Middle-aged, and Elderly Patients
Kazama, Tomiei M.D.*; Takeuchi, Ken M.D.†; Ikeda, Kazuyuki M.D., Ph.D., F.R.C.A.‡; Ikeda, Takehiko M.D.§; Kikura, Mutsuhito M.D.§; Iida, Takayuki M.D.†; Suzuki, Shuji M.D.†; Hanai, Hiroyuki M.D.∥; Sato, Shigehito M.D.#
Background: Suitable propofol plasma concentrations during gastroscopy have not been determined for suppressing somatic and hemodynamic responses in different age groups.
: Propofol sedation at target plasma concentrations from 0.5 to 4.0 μg/ml were performed randomly in three groups of patients (23 per group) who were undergoing elective outpatient gastroscopy: ages 17–49 yr (group 1), 50–69 yr (group 2), and 70–89 yr (group 3). Plasma propofol concentration in which 50% of patients do not respond to these different stimuli were determined by logistic regression: verbal command (Cp50
ls), somatic response to gastroscopy (Cp50
endo), and gag response to gastroscopy (Cp50
gag). Hemodynamic responses were also investigated in the different age groups.
ls concentrations were 2.23 μg/ml (group 1), 1.75 μg/ml (group 2), and 1.40 μg/ml (group 3). The Cp50
endo values in groups 1 and 2 were 2.87 and 2.34 μg/ml, respectively, which were significantly higher than their respective Cp50
ls values. Cp50
endo value in group 3 was 1.64 μg/ml, which was close to its Cp50
ls value. Because of a high degree of interpatient variability, Cp50
gag could not be defined. Systolic blood pressure response decreased with increasing propofol concentrations.
Conclusions: The authors determined the propofol concentration necessary for gastroscopy and showed that increasing age reduces it. Propofol concentration that suppresses somatic response induces loss of consciousness in almost all young patients.
OUTPATIENT gastrointestinal endoscopy necessitates reliable sedation involving rapid onset, short predictable duration of action, and rapid elimination without side effects. 1,2
Because of its favorable pharmacokinetic characteristics and recovery profile, propofol has increasingly become the drug of choice for maintaining adequate sedation during monitored anesthesia care, 3,4
including upper gastrointestinal endoscopy. 5
However, inappropriate sedation with propofol can cause apnea and hemoglobin oxygen desaturation. 6,7
Therefore, the narrow therapeutic range of propofol must be determined and carefully maintained. Target controlled infusion (TCI) has theoretical advantages over manual controlled infusion in sustaining the narrow therapeutic range of propofol, 8
and TCI provides satisfactory sedation conditions for upper gastroscopy. 6
However, little is known about the plasma concentration suitable to suppress somatic and hemodynamic responses during gastroscopy.
In endoscopy, sedation may make the procedure more tolerable for the patient but may contribute to cardiorespiratory risk, especially in elderly patients. 9–13
The propofol plasma concentration necessary for gastroscopy and the effects on somatic and hemodynamic responses to this stimulus has not been investigated precisely.This study was designed (1) to determine the plasma propofol concentrations at which somatic or gag responses to insertion of a gastroscope are suppressed in 50% of patients (Cp50
endo and Cp50
gag); (2) to compare those responses with the plasma propofol concentration at which 50% of patients do not respond to verbal command (Cp50
ls); and (3) to measure the hemodynamic responses to insertion of a gastroscope in young, middle-aged, and elderly patients.
Materials and Methods
The study was approved by the District Hamamatsu University Hospital Ethics Committee. After obtaining written informed consent from all subjects, we studied three groups of 23 patients each, aged 17–49 yr (group 1), 50–69 yr (group 2), and 70–89 yr (group 3), who were undergoing elective outpatient upper gastrointestinal endoscopy. All subjects were unpremedicated American Society of Anesthesiologists physical status I or II with no known or suspected cardiac, pulmonary, liver, renal, or metabolic diseases. Patients with significant obesity (body mass index > 30) or with neurologic dysfunction were excluded from the study. No topical pharyngeal anesthesia was used before the experiments.
Stable blood concentrations of propofol were achieved using a pharmacokinetic model-driven infusion device designed for computer-assisted continuous infusion, which was described precisely in our previous report. 14
The pharmacokinetic parameters used in TCI for propofol were reported previously by Gepts et al.15
For each pair of predicted and measured values, the prediction error and absolute prediction error 16
An intravenous cannula was placed in the left antecubital vein for the infusion of propofol. A 22-gauge radial artery catheter, for blood sampling only, was also inserted. Parameters that were monitored included noninvasive blood pressure (1-min intervals), heart rate, electrocardiogram, and pulse oximeter. Within each group, patients were randomized to receive predetermined target concentrations of propofol ranging from 0.25 to 4.0 μg/ml (fig. 1
). These values were selected on the basis of our previous experience with propofol Cp50
To ensure equilibration between plasma and effect compartment, the predetermined target concentration (fig. 1
) was maintained for 15 min before verbal command and insertion of an endoscope. Arterial blood samples for plasma propofol concentration were taken 10 and 14 min after the start of infusion. Only paired samples that had concentrations within ±30% of each other were analyzed statistically.
After a 15-min equilibration period of the predetermined propofol blood concentration (set by TCI), a verbal command to open their eyes was given to the patients one or two times. One minute after giving the verbal command, the endoscopist, who was blinded to the target propofol concentration, performed the gastroscopy with an Olympus endoscope (GIF-Q200; Olympus, Tokyo, Japan). Somatic response was noted and classified as positive if the patient showed a gross purposeful movement of the head or extremities. The presence or absence of gagging was also noted when the endoscope was inserted. Coughing during insertion was not considered a positive response. The responses to verbal command and to insertion of gastroscopy at one predetermined propofol concentration as shown in figure 1
were measured to obtain Cp50
When gag or somatic response was positive, target concentration was increased by 0.5 or 1.0 μg/ml after a 10- or 20-mg propofol bolus dose. When it was impossible to insert an endoscope at that dose, the target concentration was increased further by 0.5 or 1.0 μg/ml after another 10- or 20-mg propofol bolus dose. When gag or somatic response was negative, target concentration was decreased if hypotension or bradycardia occurred. The bolus infusion doses given by the TCI device in the manual mode were taken into consideration in the model. During examination by gastroscope, the target propofol concentration of each patient was continually adjusted within a range of 1 and 3 μg/ml. The data of no response and response during gastroscopy after gastroscope insertion were not used to determine Cp50 values. Adjustments were made to ensure that the patient did not show inappropriate movements, was resting comfortably, had stable cardiovascular and respiratory functions, and could be examined using an endoscope.
Systolic blood pressure (SBP) and heart rate were recorded before insertion of an endoscope. The mean value during the 2 min before insertion was considered the prestimulation value. For the poststimulation value, the maximum value during the 2 min after insertion of the gastroscope was recorded. Linear regression analysis was used to correlate the SBP and heart rate values of all patients with the propofol concentrations. The numeric increase values at insertion of a gastroscope were obtained at the Cp50endo and the Cp95endo with linear regression.
Somatic and autonomic responses were identified by the same attending anesthesiologist, who was blinded to the target concentration. All patients breathed room air throughout the procedure. Patients with 3 min of persistent oxygen saturation nadir < 90%, as monitored by a pulse oximeter, were given nasal oxygen (3 l/min). If hypotension (< 80 mmHg systolic arterial pressure) or bradycardia (< 45 beats/min) persisted, the patient’s blood pressure was restored by a combination of fluid, ephedrine, and decreasing of target propofol concentration, and heart rate was restored by atropine (0.25 mg administered intravenously). The incidents of complications and untoward events requiring intervention were documented. These included respiratory depression, excessive pain, inappropriate movements, and inability to examine the patient.
For responses to verbal command and insertion of an endoscope, each patient’s clinical state was categorized as “responsive” or “nonresponsive” based on the aforementioned criteria. Within the three response categories, data for all patients were pooled. For determination of Cp50
values, we only used the data of responses at the predetermined equilibrated propofol concentration, as shown in figure 1
. The response–nonresponse data overlapped and was related to the propofol concentration according to following equation:MATH
where Cp is the measured propofol concentration in plasma, Cp50
is the plasma concentration of propofol that results in a 50% probability of no response, and γ is a dimensionless power function that determines the steepness of the slope of the probability versus
concentration curve. Cp50
endo, and Cp50
gag were calculated by logistic regression (Microsoft Excel 8.0; Microsoft Co., Seattle, WA). To investigate the relation between continuous age values and Cp50
values, the age-dependent concentration at which 50% of the patients show no responses to verbal command or insertion of a gastroscope was calculated by applying the following formula: MATH
where the parameters a and b were estimated by all 69 observations. 17
Blood samples were kept on ice and stored at 5°C until extraction and assay. Plasma concentrations of propofol were determined using high-performance liquid chromatography with fluorescence detection at 310 nm after excitation at 276 nm (CTO-10A, RF550, and C-R7A; Shimazu, Kyoto, Japan). 18
For each batch of blood samples (representing one patient), a separate standard curve was computed by adding pure propofol emulsion to human plasma to concentrations of 1.0, 5.0, and 10.0 μg/ml. Linear regression (method of least squares) was used with the plasma propofol concentration as the dependent variable. Propofol concentrations in this study were calculated with the derived regression equation. The lower limit of detection was 14 ng/ml, and the coefficient of variation was 7.6%.
One-way analysis of variance was used to determine if a significant difference (P < 0.05) existed between the mean values of Cp50 for the various responses within each group. Multiple two-tailed unpaired t tests with Bonferroni correction were performed to determine significance (P < 0.05) between groups.
All 69 patients (23 per group) completed the study. Demographic characteristics for the three groups are shown in table 1
. There were no statistically significant differences between the groups in gender or duration of endoscopy. Total propofol infusion dose and mean target concentration during endoscopic procedure was significantly lower in groups 2 and 3 than in group 1. In our protocol, all patients were examined easily by endoscopy and showed no inappropriate movements.
Transient hypotension was observed in three patients in group 3. In two of these patients, normotension was restored by insertion of an endoscope without any treatment. The hypotension of the other patient was alleviated by a combination of fluid infusion and decrease in target propofol concentration. No patients suffered from bradycardia, and none showed electrocardiographic changes from baseline. In two patients from group 3, oxygen saturation decreased < 90% transiently after insertion of the endoscope but was restored to normal within a few minutes without treatment. No patients developed laryngospasm on insertion of the endoscope. In the present study, the average duration of a procedure was approximately 9 min (table 1
), and all patients were awake and coherent in < 10 min after the end of the procedure. There were no other adverse effects during this study.
Median prediction error and median absolute prediction error for TCI administration of propofol were 5.4% and 8.4%, respectively. Responses to verbal command, somatic response to gastroscope insertion, and gag response to gastroscope insertion and concentration–effect curves in each age group are shown in figure 2
ls and Cp50
endo were decreased significantly with increasing age (P
< 0.05;table 2
), and they were calculated as Cp50
ls = 2.95 − 0.021 · age and as Cp50
endo = 3.74 − 0.026 · age. In both the young and middle-aged groups, Cp50
endo values were significantly higher (P
< 0.05) than their Cp50
ls values. However, the Cp50
ls and Cp50
endo values were similar in the elderly group. The percent probabilities of no response to verbal command at Cp50
endo of groups 1, 2, and 3 were 99%, 93%, and 73%, respectively, i.e.
, the propofol concentration that suppressed somatic response induced loss of consciousness in almost all patients in groups 1 and 2.
The concentration–effect curve of gag response was not particularly steep, and it was impossible to define a threshold at which propofol suppressed gag response. Average target concentrations during gastroscopy in groups 1, 2, and 3 were 2.61, 2.17, and 1.36 μg/ml, respectively (table 1
), which were lower than the respective values of Cp50
endo. These results demonstrate that insertion of a gastroscope was the most intense stimulus during intestinal gastroscopy.
The dose-dependent increase in sedation produced by propofol was paralleled by a decrease in SBP just before insertion of the gastroscope. SBP response on insertion decreased with increasing propofol plasma concentrations (fig. 3
). SBP response at Cp50
endo in patients older than 70 yr was 36.9 mmHg, which was higher than the 21.4-mmHg average in young patients. Heart rate response to gastroscope insertion was minimal (fig. 4
Although endoscopy can be performed without intravenous sedation, tolerance is lower in unsedated patients than in sedated patients, especially during a prolonged procedure. In addition, endoscopy necessitates relative immobility throughout, which can be difficult for an unsedated patient to maintain. Propofol provides rapid onset, short predictable duration of action, and rapid elimination. However, if patients are not sedated appropriately, propofol may cause apnea and hemoglobin oxygen desaturation. 6,7
Avramov and White 4
described safe, effective anesthesia procedures for outpatient monitored anesthesia care with carefully titrated propofol and alfentanil. Recognition of exactly what propofol concentration will be safe for gastrointestinal endoscopy is crucial. To enable precise, correct concentrations for different age groups, we determined various Cp50
values related to the insertion of a gastroscope, which is thought to be one of the strongest stimuli encountered during endoscopy.
ls, we previously reported that equilibrated awakening propofol concentration was 2.2 μg/ml. 19
Schnider et al.17
reported increasing sensitivity to propofol in elderly patients, with Cp50
ls at 2.35, 1.8, and 1.25 μg/ml, in patients aged 25, 50, and 75 yr, respectively. Smith et al.20
showed that the Cp50
ls was decreased by increasing age. These values are consistent with our Cp50
ls values in the present study. Church et al.6
demonstrated that TCI of propofol provided satisfactory sedation conditions during upper gastrointestinal endoscopy. They reported that the median predicted blood propofol concentration necessary for gastroscope insertion in 20- to 76-yr-old patients was 2.5 μg/ml. Although they did not examine the relation between age and propofol concentration necessary for gastroscope insertion, their reported median value was close to the 2.34 μg/ml of our Cp50
endo in 50- to 69-yr-old patients. In the present study, we determined that both Cp50
ls and Cp50
endo decreased significantly (P
< 0.05) in the elderly patients.
There has been no previous precise report of the relation between Cp50
ls and Cp50
endo. According to our findings of Cp50
ls and Cp50
endo in various age groups, Cp50
ls was significantly lower than Cp50
endo in 17- to 69-yr-old patients. In the patients aged 17–49 yr, Cp95
ls (propofol concentration at which 95% of patients did not respond to verbal command) was 2.67 μg/ml, a level at which somatic response to gastroscope insertion was suppressed in only 30% of group 1 patients (fig. 2
). In other words, the propofol concentration necessary to suppress somatic response to gastroscope insertion produced loss of consciousness in most 17- to 49-yr-old patients. If conscious sedation is defined as when a patient is resting comfortably but is easily arousable and alert enough to obey commands, conscious sedation may be inappropriate for gastroscopy in patients within this age range. In patients aged 70–89 yr, the Cp50
ls value was close to the Cp50
endo value. That means conscious sedation can be performed easily in these patients.
We speculate that gag reflex, similar to cough reflex, is originally a variable reflex depending on individual patient and that propofol concentration to block the gag response is also variable compared with response to verbal command or purposeful somatic response to insertion of a gastroscope in our study. No topical pharyngeal anesthesia was used in this study, which might have given emphasis on gag reflex.
Previous reviews of major complications during gastrointestinal endoscopy point out that cardiopulmonary problems account for 50% of morbidity and 60% of deaths. 11,21,22
Carter et al.10
reported that more than 60% of deaths occurring after gastrointestinal endoscopy are related to cardiorespiratory complications. In our study, SBP response on insertion of an endoscope decreased with increasing propofol plasma concentration (fig. 3
), and preventing such SBP responses may decrease the incidence of cardiopulmonary complications. However, in elderly patients, SBP increased by 37% at the propofol Cp50
endo level (1.64 μg/ml). By the use of higher propofol concentrations, the SBP response can be suppressed even when elderly patients show indications before the beginning of gastroscopy that they may be susceptible to a potentially dangerous SBP decrease during the procedure.
Furthermore, the insertion may cause a decrease in oxygen saturation. Blouin et al.7
reported that a propofol concentration as low as 2.0 μg/ml decreased the hypoxic ventilatory response in even young volunteers. When titrating propofol concentration during gastroscopy, it is necessary to consider both sedative action and influence on cardiorespiratory function. Compared with SBP response, heart rate response to gastroscope insertion was minimal in the present study. In a previous report, propofol was associated with a significantly slower heart rate than was midazolam. 1
This effect of propofol has been demonstrated by other investigators and may be beneficial because it reduces myocardial oxygen demand. 23
Our results will enable the endoscopist to select, with a greater degree of confidence, a target blood concentration that should produce adequate sedation while at the same time minimizing the risk of hypertension or hypotension in various age groups.
The risk of arrhythmias may be increased during periods of arterial desaturation. 12
Lieberman et al.9
found that diazepam sedation during endoscopy represents a potential danger to patients with marginal arterial oxygen saturation, and they concluded that diazepam should be used cautiously, if at all, in this population. There is a reduction in oxygen saturation after sedation for endoscopy, which compounds that which occurs after endoscopic intubation alone. 13,24,25
In our study, oxygen saturation decreased to < 90% transiently after gastroscope insertion in only two patients from group 3, and this reduction was reversed in a few minutes without treatment. Although few elderly patients suffered transient oxygen desaturation in our study, its clinical importance is obvious. If sedation is necessary in elderly patients with marginal arterial oxygen saturation, supplemental oxygen should be used. 9,26
In conclusion, Cp50ls and Cp50endo decreased significantly as age increased. To suppress the somatic response to gastroscope insertion in young and middle-aged patients, higher plasma propofol concentration than the Cp50ls value is necessary. In elderly patients, the plasma propofol concentration for Cp50ls is sufficient to suppress somatic response during insertion of a gastroscope. SBP response on gastroscope insertion decreased with increasing propofol plasma concentration. SBP response in elderly patients was higher than that in young and middle-aged patients.
1. Patterson KW, Casey PB, Murray JP, O’Boyle CA, Cunningham AJ: Propofol sedation for outpatient upper gastrointestinal endoscopy: Comparison with midazolam. Br J Anaesth 1991; 67: 108–11
2. Donnelly MB, Scott WA, Daly DS: Sedation for upper gastrointestinal endoscopy: A comparison of alfentanil-midazolam and meperidine-diazepam. Can J Anaesth 1994; 41: 1161–5
3. Smith I, White PF, Nathanson M, Gouldson R: Propofol: An update on its clinical uses. A nesthesiology 1994; 81: 1005–43
4. Avramov MN, White PF: Use of alfentanil and propofol for outpatient monitored anesthesia care: Determining the optimal dosing regimen. Anesth Analg 1997; 85: 566–72
5. Carlsson U, Grattidge P: Sedation for upper gastrointestinal endoscopy: A comparative study of propofol and midazolam. Endoscopy 1995; 27: 240–3
6. Church JA, Stanton PD, Kenny GNC, Anderson JR: Propofol for sedation during endoscopy: Assessment of a computer-controlled infusion system. Gastrointest Endosc 1991; 37: 175–9
7. Blouin RT, Seifert HA, Babenco HD, Conard PF, Gross JB: Propofol depresses the hypoxic ventilatory response during conscious sedation and isohypercapnia. A nesthesiology 1993; 79: 1177–82
8. Engbers HFM: Target-controlled infusion in practice. Eur J Anaesth 1995; 10: 88–90
9. Lieberman DA, Wuerker CK, Katon RM: Cardiopulmonary risk of esophagogastroduodenoscopy: Role of endoscope diameter and systemic sedation. Gastroenterology 1985; 88: 468–72
10. Carter AS, Coady T, Bell GD, Lee J, Morden A: Monitoring during sedation for endoscopy. Br Med J 1989; 298: 114
11. Mathew PK, Ona FV, Damevski K, Wallace WA: Arrhythmias during upper gastrointestinal endoscopy. Angiology 1979; 30: 834–40
12. Rostykus PS, Mcdonald GB, Albert PK: Upper intestinal endoscopy induces hypoxemia in patients with obstructive pulmonary disease. Gastroenterology 1980; 78: 488–91
13. Whorwell PJ, Smith CL, Foster KJ: Arterial blood gas tensions during upper gastrointestinal endoscopy. Gut 1976; 17: 797–800
14. Kazama T, Ikeda K, Morita K: Reduction by fentanyl of the Cp50 values of propofol and hemodynamic responses to various noxious stimuli. A nesthesiology 1997; 87: 213–27
15. Gepts E, Jonckheer K, Maes V, Sonck W, Camu F: Disposition kinetics of propofol during alfentanil anaesthesia. Anaesthesia 1988; 43 (suppl): 8–13
16. Varvel JR, Donoho DL, Shafer SL: Measuring the predictive performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm 1992; 20: 63–94
17. Schnider TW, Minto CF, Shafer SL, Gambus PL, Andresen C, Goodale DB, Young EJ: The influence of age on propofol pharmacodynamics. A nesthesiology 1999; 90: 1502–16
18. Plummer GF: Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987; 421: 171–6
19. Kazama T, Ikeda K, Morita K, Sanjo Y: Awakening propofol concentration with and without blood-effect site equilibration after short-term and long-term administration of propofol and fentanyl anesthesia. A nesthesiology 1988; 88: 928–34
20. Smith C, McEwan AI, Jhaveri R, Wilkinson M, Goodman D, Smith R, Canada AT, Glass PSA: The interaction of fentanyl on the cp50 of propofol for loss of consciousness and skin incision. A nesthesiology 1994; 81: 820–8
21. Silvis SE, Nebel O, Rogers G, Sugawa C, Mandelstam P: Endoscopic complications. JAMA 1976; 235: 923–30
22. Mandelstam P, Sugawa C, Silvis SE, Nebel O, Rogers BH: Complications associated with esophagogastroduodenoscopy and with esophageal dilatation. Gasrointest Endosc 1974; 23: 16–9
23. Patrick MR, Blair IJ, Feneck RO, Sebels PS: A comparison of the haemodynamics of propofol (Diprivan) and thiopentone in patients with coronary artery disease. Postgrad Med J 1985; 61: 23–7
24. Murray AW, Morran CG, Kenny GNC, Anderson JR: Arterial oxygen saturation during upper gastrointestinal endoscopy: The effects of a midazolam/pethidine combination. Gut 1990; 31: 270–3
25. Barkin JS, Kreiger B, Blinder M, Bosch-Blinder L, Goldberg RI, Phillips RS: Oxygen desaturation and changes in breathing pattern in patients undergoing colonoscopy and gastroscopy. Gastrointest Endosc 1989; 35: 526–30
26. Bell GD, Bown S, Morden A, Coady T: Prevention of hypoxaemia during upper-gastrointestinal endoscopy by means of oxygen via nasal cannulae. Lancet 1987; 8540: 1022–4
This article has been cited 25 time(s).
Acta Anaesthesiologica Scandinavica
Oral clonidine premedication reduces the EC50 of propofol concentration for laryngeal mask airway insertion in male patients
Acta Anaesthesiologica Scandinavica, 46(4):
DigestionThe dawning of a new sedative: Propofol in gastrointestinal endoscopyDigestion
Forensic Science InternationalSudden death with lung embolism after inadvertent infusion of zinc oxide shake lotionForensic Science International
Best Practice & Research in Clinical GastroenterologyEndoscopy in the elderly patientBest Practice & Research in Clinical Gastroenterology
Surgical Endoscopy-Ultrasound and Interventional Techniques
Lipid peroxidation and the use of emulsified propofol in laparoscopic surgery
Surgical Endoscopy-Ultrasound and Interventional Techniques, 15(9):
Gastrointestinal EndoscopyMask adaptor - a novel method of positive pressure ventilation during propofol deep sedation for upper GI endoscopyGastrointestinal Endoscopy
European Journal of Anaesthesiology
Comparison of the anaesthetic requirement with target-controlled infusion of propofol to insert the laryngeal tube vs. the laryngeal mask
European Journal of Anaesthesiology, 22():
Acta Anaesthesiologica Scandinavica
A new system to target the effect-site during propofol sedation
Acta Anaesthesiologica Scandinavica, 47(8):
Revista Espanola De Enfermedades Digestivas
Endoscopist controlled administration of propofol: an effective and safe method of sedation in endoscopic procedures
Revista Espanola De Enfermedades Digestivas, 98(1):
Bmc MicrobiologyPropofol lipidic infusion promotes resistance to antifungals by reducing drug input into the fungal cellBmc Microbiology
Zeitschrift Fur GastroenterologieS3-Guidelines - Sedation in Gastrointestinal EndoscopyZeitschrift Fur Gastroenterologie
European Journal of PharmacologyPropofol, an anesthetic possessing neuroprotective action against oxidative stress, promotes the process of cell death induced by H2O2 in rat thymocytesEuropean Journal of Pharmacology
GastroenterologyEndoscopist-Directed Administration of Propofol: A Worldwide Safety ExperienceGastroenterology
American Journal of GastroenterologySafety of propofol administered by registered nurses with gastroenterologist supervision in 2000 endoscopic casesAmerican Journal of Gastroenterology
Anesthesia and Analgesia
The interaction between propofol and clonidine for loss of consciousness
Anesthesia and Analgesia, 94(4):
Current Medicinal Chemistry
Age-Related Pharmacokinetic and Pharmacodynamic Changes and Related Risk of Adverse Drug Reactions
Current Medicinal Chemistry, 17(6):
Anesthesia and Analgesia
Early pregnancy does not reduce the C-50 of propofol for loss of consciousness
Anesthesia and Analgesia, 93(6):
American Journal of GastroenterologyNurse-administered propofol Versus midazolam and meperidine for upper endoscopy in cirrhotic patientsAmerican Journal of Gastroenterology
Acta Anaesthesiologica ScandinavicaEffect site concentrations of propofol producing hypnosis in children and adults: comparison using the bispectral indexActa Anaesthesiologica Scandinavica
EndoscopyS3 Guideline: Sedation for gastrointestinal endoscopy 2008Endoscopy
Determination of the median effective concentration (EC50) of propofol during oesophagogastroduodenoscopy in children
Paediatric Anaesthesia, 11(5):
Advances in Modelling and Clinical Application of Intravenous Anaesthesia
Age related changes of the PK-PD of intravenous anaesthetics
Advances in Modelling and Clinical Application of Intravenous Anaesthesia, 523():
Comprehensive PhysiologyEffects of Anesthetics, Sedatives, and Opioids on Ventilatory ControlComprehensive Physiology
Cardiology in ReviewCardiovascular Considerations in Patients Undergoing Gastrointestinal EndoscopyCardiology in Review
Monitored anesthesia care; sedation; target-controlled infusion.
© 2000 American Society of Anesthesiologists, Inc.
Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.
Highlight selected keywords in the article text.